全文获取类型
收费全文 | 2769篇 |
免费 | 145篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 29篇 |
妇产科学 | 9篇 |
基础医学 | 211篇 |
口腔科学 | 203篇 |
临床医学 | 251篇 |
内科学 | 305篇 |
皮肤病学 | 5篇 |
神经病学 | 94篇 |
特种医学 | 87篇 |
外国民族医学 | 1篇 |
外科学 | 853篇 |
综合类 | 358篇 |
预防医学 | 117篇 |
眼科学 | 43篇 |
药学 | 200篇 |
2篇 | |
中国医学 | 30篇 |
肿瘤学 | 163篇 |
出版年
2023年 | 37篇 |
2022年 | 91篇 |
2021年 | 129篇 |
2020年 | 104篇 |
2019年 | 87篇 |
2018年 | 84篇 |
2017年 | 83篇 |
2016年 | 83篇 |
2015年 | 88篇 |
2014年 | 188篇 |
2013年 | 196篇 |
2012年 | 154篇 |
2011年 | 198篇 |
2010年 | 156篇 |
2009年 | 126篇 |
2008年 | 168篇 |
2007年 | 117篇 |
2006年 | 105篇 |
2005年 | 82篇 |
2004年 | 75篇 |
2003年 | 60篇 |
2002年 | 45篇 |
2001年 | 43篇 |
2000年 | 43篇 |
1999年 | 36篇 |
1998年 | 37篇 |
1997年 | 35篇 |
1996年 | 25篇 |
1995年 | 27篇 |
1994年 | 38篇 |
1993年 | 39篇 |
1992年 | 28篇 |
1991年 | 14篇 |
1990年 | 15篇 |
1989年 | 16篇 |
1988年 | 11篇 |
1987年 | 12篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1974年 | 5篇 |
1972年 | 6篇 |
1971年 | 8篇 |
1969年 | 6篇 |
1968年 | 8篇 |
排序方式: 共有2999条查询结果,搜索用时 31 毫秒
1.
Michael A. Gibney David Fitz-Patrick David C. Klonoff Shahista Whooley Betty Lu Wen Yue 《Current medical research and opinion》2020,36(10):1591-1600
Abstract
Objective
Two similarly designed studies compared user experiences with a second-generation extra-thin-wall, 5-bevel 32?G?×?4?mm pen needle (PN) with redesigned hub versus four thinner commercially available PNs. 相似文献2.
《Drug metabolism and pharmacokinetics》2019,34(1):87-94
The purpose of this study was to elucidate the involvement of Mate1 in the tubular secretion of trimethoprim and saturation of Mate1-mediated efflux to address the mechanisms underlying the pharmacokinetic drug interactions with trimethoprim. Trimethoprim is a more potent inhibitor of MATE2-K than MATE1 with Ki values (μM) of 0.030–0.28 and 2.4–5.9, respectively. Trimethoprim is a substrate of human MATE1 and MATE2-K with Km values of 2.3 ± 0.9 and 0.018 ± 0.004 μM, and mouse Mate1, but not human OCT2, mouse Oct1 and Oct2. Pyrimethamine significantly reduced the renal clearance (CLR) of trimethoprim (mL/min/kg) from 40.0 ± 5.1 to 20.1 ± 3.7 (p < 0.05). Trimethoprim was given to mice at three infusion rates (150, 500, and 1500 nmol/min/kg). Together with an increase in the plasma concentrations of trimethoprim, the CLR (mL/min/kg) of trimethoprim decreased to 25.9 ± 3.2, 13.5 ± 5.7, and 8.92 ± 1.50 at the respective rates. Trimethoprim decreased the CLR of rhodamine 123 in an infusion rate-dependent manner: 11.5 ± 1.3 (control), 5.17 ± 1.55, 1.31 ± 0.50, and 0.532 ± 0.180. These results suggest that Mate1 mediates the tubular secretion of trimethoprim, and at therapeutic doses, MATEs-mediated efflux can be saturated, and thereby, cause drug interactions with other MATE substrates. 相似文献
3.
目的:探讨低位直肠癌保肛术后吻合口漏的原因及合理有效的防治方法。方法:对我院近10年来出现的低位直肠癌全系膜切除低位吻合手术后吻合口漏的发生及治疗情况进行回顾性分析。对吻合口漏的患者采用手术及保守治疗(骶前双腔管冲洗引流加肛管引流)。结果:共行低位保肛手术348例,术后发生吻合口漏11例,吻合口漏的发生率为3.2%。患者的年龄、吻合技术和肿瘤组织学分型与吻合口漏的发生无关。而患者的性别、肿瘤的大小与吻合口漏的发生密切相关(P〈0.05)。11例患者中有3例行手术治疗(HA手术),8例采用保守治疗后均痊愈出院,吻合口漏发生至出院时间平均为10~15d。结论:充分的术前准备和良好的吻合技术是防止吻合口漏发生的关键。正确判断吻合口漏的发生及采用正确的处理方法是治疗的前提,双腔引流管加肛管引流是保守治疗吻合口漏的有效方法。 相似文献
4.
Kousaku Matsubara M.D. Kei Suzuki M.D. Ying Wei Lin M.D. Toshiyuki Yamamoto M.D. Shigeru Ohta M.D. 《Pediatrics international》1991,33(4):482-487
We present two female siblings with familial juvenile nephronophthisis (FJN) which was diagnosed at the early stage of renal failure. Diagnosis was made during the investigation of anemia in case 1 and by a subsequent family survey in case 2. Most patients with FJN are not identified until the terminal stage of renal failure and such cases have rarely been reported in Japan. Case 2 had a reduction in the maximum urinary concentration ability but no azotemia, and among the FJN patients reported in Japan so far she has the least advanced renal disease. Histological examination of the renal biopsy in case 1 showed typical findings of FJN, such as thickening and lamination of the tubular basement membrane (TBM), interstitial fibrosis, and round cell infiltration of the interstitium. In case 2, renal biopsy revealed an irregular marked thickening of the TBM with trivial interstitial changes and a normal glomerular appearance. The histology of these two cases suggests that the TBM may be the primary site affected in FJN. 相似文献
5.
2003年12月30日一辆装载7.28t苯胺的槽车从宁波开往温州的路上在甬台温高速公路温岭市境内翻车,造成5.3t左右的苯胺泄漏在高速公路旁的环境中,除少量的液体被清除外,绝大部分渗入地下,造成了水井污染.从12月31日开始我们对周围的水井开展了监测,现将监测结果分析如下: 相似文献
6.
Björn-Christian Link Emre F. Yekebas Dean Bogoevski Asad Kutup Gerhard Adam Jakob R. Izbicki Gerrit Krupski 《Journal of gastrointestinal surgery》2007,11(2):166-170
Symptomatic biliary leakage following major upper abdominal surgery is a severe complication resulting in increased morbidity
and mortality. Treatment options usually include either endoscopic intervention or surgical revision. These options may be
burdened by a high perioperative risk for the patient (e.g., patients with severe disease) or simply may not be possible (e.g.,
nonpreserved gastroduodenal passage). In the past, percutaneous transhepatic cholangiodrainage did only seem to be a viable
option for patients with dilated bile ducts. Here, we present our experience in a consecutive series of patients with symptomatic
biliary leakage following major upper abdominal surgery and without dilation of the biliary system that underwent percutaneous
transhepatic cholangiodrainage. Percutaneous transhepatic cholangiodrainage was feasible in 15 of 18 patients (83.3%). The
procedure was technically not possible in three patients (16.7%). In 10 of the 15 patients (66.6%) with feasible percutaneous
transhepatic cholangiodrainage, biliary leakage was definitely controlled without the need for surgical revision. Depending
on the experience with the interventional procedure, percutaneous transhepatic cholangiodrainage should be considered as an
alternative for treatment of symptomatic biliary leakage instead of immediate reoperation.
Presented at the Digestive Disease Week 2005 (DDW), Chicago, IL, May 14–19, 2005 (poster presentation). 相似文献
7.
Chien-Huang Lin Feng-Nien Ko Hisahi Ishii Tsutomu Ishikawa Ih-Sheng Chen Che-Ming Teng H.-P. Kuo 《Naunyn-Schmiedeberg's archives of pharmacology》1997,355(2):210-216
We investigated the effects of a novel platelet-activating factor (PAF) receptor antagonist, CIS-19 [cis-2-(3, 4-dimethoxyphenyl)-6-isopropoxy-7-methoxy-1-(N-methylformamido)-1,
2, 3, 4-tetrahydronaphthalene], on PAF-, histamine-, substance P- and antigen-induced bronchoconstriction and microvascular
leakage, as well as PAF- and antigen-induced bronchial hyperreactivity to methacholine in urethane-anesthetized guinea-pigs.
Administration of CIS-19 (0.5–5 mg/kg, i.v.) inhibited the increase in lung resistance induced by PAF (30 ng/kg, i.v.) in
a dose-dependent manner, but failed to inhibit the increase induced by histamine (30 μg/kg, i.v.) or substance P (6.5 μg/kg,
i.v.). CIS-19 (5 mg/kg, i.v.) did not inhibit the increase in lung resistance induced by ovalbumin (2 mg/kg, i.v.) in actively
sensitized guinea-pigs. PAF (30 ng/kg, i.v.)-induced microvascular leakage, measured by the extravasation of Evans blue dye,
was dose-dependently inhibited by CIS-19 (0.5–5 mg/kg, i.v.) in the trachea, main bronchi and intrapulmonary airways, but
it did not affect histamine (30 μg/kg, i.v.)- or substance P (6.5 μg/kg, i.v.)-induced microvascular leakage at all airway
levels. CIS-19 (2.5 and 5 mg/kg) did not affect ovalbumin (2 mg/kg, i.v.)-induced microvascular leakage in all airway levels
in actively sensitized guinea-pigs. CIS-19 (2.5 and 5 mg/kg, i.v.) significantly inhibited PAF-induced enhancement of the
bronchial response to methacholine, but had no effect on ovalbumin (0.05 mg/kg, i.v.)-induced bronchial hyperreactivity in
actively sensitized guinea-pigs. It is concluded that CIS-19 is a potent PAF receptor antagonist which inhibits PAF- but not
antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity. These results suggest that PAF plays
little or no role in early airway responses following antigen challenge.
Received: 29 April 1996 / Accepted: 10 October 1996 相似文献
8.
Age, hematopoietic growth factors, cyclosporin A, mode of bone marrow transplantation (BMT) (autologous, allogeneic-related,
unrelated), and underlying disease were assessed as potential risk factors for capillary leakage syndrome (CLS) in 96 patients
after BMT. CLS was defined as unexplained weight gain of >3% within 24 h and nonresponsiveness to furosemide. CLS occurred
in 9/21 patients after unrelated compared with 2/33 after allogeneic-related BMT (p=0.0017) for hematopoietic disorders (n=54) and in 6/7 patients after allogeneic-related compared with 3/35 after autologous BMT (p=0.0001) for solid tumors (n=42). Hematopoietic growth factors and cyclosporin A were no signficant risk factors on their own. We conclude that unrelated
BMTs or high-intensity conditioning regimens used in combination with allogeneic-related BMT are the main risk factors for
CLS.
Received: 6 January 1997 / Accepted: 10 March 1997 相似文献
9.
Emine Sözeri Dietrich Feist Hans Ruder Karl Schärer 《Pediatric nephrology (Berlin, Germany)》1997,11(3):307-311
Renal lesions have repeatedly been described in Wilson’s disease (WD). We investigated the excretion of total protein, albumin,
low (LMW) and high molecular weight (HMW) proteins, N-acetyl-β-D-glucosaminidase (NAG), and calcium, as well as creatinine clearance, in 24-h urine samples of 41 patients with WD aged 6 – 37
(mean 17) years who had been treated for a period of 0 – 15 (mean 4.5) years with D-penicillamine (900 mg/day). The amount of all protein excreted was significantly increased compared with controls, 39% of
patients presenting with total proteinuria more than two standard deviations from the mean of controls. The changes in protein
excretion depended on the duration of treatment. LMW proteinuria was elevated almost exclusively in the first 2 years after
the start of treatment, indicating early tubular damage. This is supported by an initially high excretion of β2-microglobulin, NAG, and calcium. Increased excretion of HMW proteins, including albumin, persisted over longer periods, which
suggests glomerular injury in some patients, possibly related to the use of D-penicillamine. Creatinine clearance remained roughly within normal limits. We propose that renal function should regularly
be checked in patients with WD.
Received October 26, 1995; received in revised form August 27, 1996; accepted September 20, 1996 相似文献
10.
当归或三七对兔甘油致急性肾衰的保护作用及其机制研究 总被引:14,自引:1,他引:13
目的:用甘油复制兔急性肾小管坏死(ATN)模型,观察当归、三七对ATN的保护作用,并初步探讨其机制。方法:40只健康新西兰白色家兔,等分为四组:当归组、三七组、对照组、正常组。当归、三七、对照三组均用50%甘油等渗盐水15ml/kg注入兔双后肤皮下,复制ATN模型,当归组于注射甘油后即刻,第3小时,第6小时,肌注当归注射液50mg/kg,三七组于相同时点肌注三七皂甙50mg/kg,正常组则于兔双后肢皮下注射生理盐水15ml/kg,并于相同时点注射5%葡萄糖注射液。于实验第24小时取血液、尿液和肾脏,检测血清尿素氮、肌酐、尿液总渗透压、尿总氨基酸、肾组织MDA、SOD、GSH—PX、ATP酶、Ca2^ 、肾组织病理形态学检查。结果:各组与正常组比,肌酐、尿素氮明显升高,说明模型复制成功。当归、三七纪元l例死亡,对照组死士率为30%,血清肌酐、尿素氮、丙二醛、尿总氨基酸、滤过钠排泄分数和肾组织钙含量均明显低于对照组(P<0.01),而肾组织ATP酶、SOD、GSH-PX活性均高于对照组(P<0.01),病理形态学变化轻于对照组。以上指标,当归与三七组无显著差异(P>0.05)。结论:当归、三七对甘油所致的ATN有明显保护作用,二者效果无差异,其机制可能与二者均有改善微循环、血液流变学、抑制脂质过氧化反应、保护肾脏抗氧化酶和ATP酶活性及减轻肾组织钙超载有关。 相似文献